Congenital Hypothyroidism in Pediatrics: High-Yield | MDster                                                    You are offline

     Back online!

  [  ](/)

  Specialities     [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics &amp; Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry)

 [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog)

 Menu

  Specialities     [ Anesthesiology ](https://mdster.com/speciality/anesthesiology) [ Emergency Medicine ](https://mdster.com/speciality/emergency-medicine) [ Family Medicine ](https://mdster.com/speciality/family-medicine) [ Internal Medicine ](https://mdster.com/speciality/internal-medicine) [ Obstetrics &amp; Gynecology ](https://mdster.com/speciality/obstetrics-gynecology) [ Pediatrics ](https://mdster.com/speciality/pediatrics) [ Psychiatry ](https://mdster.com/speciality/psychiatry)

 [ Features ](https://mdster.com/features) [ Pricing ](https://mdster.com/pricing) [ Blog ](https://mdster.com/blog)

 [     Login    ](https://mdster.com/auth/login)

      1. [        Home  ](https://mdster.com)
2. [   Blog  ](https://mdster.com/blog)
3. [   Medical Education  ](https://mdster.com/blog?category=medical-education)
4. Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes

  [ Medical Education ](https://mdster.com/blog?category=medical-education)

 Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes
===============================================================

  A high-yield pediatric approach to newborn screen detection, why treatment cannot wait, and how follow-up protects neurodevelopment

  [     MDster Editorial Team ](https://mdster.com/about) ·      Apr 04, 2026  ·      6 min read  ·       71

  [     Reviewed by Dr. Ali Ragab, MBBCH, MSc, MCAI ](https://mdster.com/medical-reviewers/dr-ali-ragab) [Editorial Policy](https://mdster.com/editorial-policy) | [Corrections Policy](https://mdster.com/corrections)

    [ Pediatrics ](https://mdster.com/blog?tag=pediatrics) [ Endocrinology ](https://mdster.com/blog?tag=endocrinology) [ Newborn Screening ](https://mdster.com/blog?tag=newborn-screening) [ Thyroid Disorders ](https://mdster.com/blog?tag=thyroid-disorders)

    ![Congenital Hypothyroidism: Screening, Levothyroxine, Outcomes](https://mdster.com/storage/blog/images/congenital-hypothyroidism-screening-levothyroxine-outcomes.jpg)

    Share this article

        Share this post

 The dangerous part of **congenital hypothyroidism (CH)** is that the newborn often looks well. Maybe there is mild jaundice, sleepy feeding, or nothing at all. Meanwhile, untreated hypothyroidism is injuring a hormone-dependent brain. That is why CH remains a boards favorite: it is one of the few pediatric endocrine diagnoses where screening, rapid confirmation, and immediate treatment clearly change developmental outcome. [\[1\]](#cite-1 "Reference [1]")

Newborn screen detection: trust the system, but know its blind spots
--------------------------------------------------------------------

In the United States, CH is routinely detected by dried blood spot newborn screening from a heel stick, usually collected around **24 to 48 hours after birth**. Collection before 24 hours can mislead because of the physiologic postnatal TSH surge. Programs do not all use the same strategy: some are **primary TSH**, some **primary T4 with backup TSH**, and some combine both. So, know your local lab algorithm. Most importantly, an abnormal screen is **not** the diagnosis; send **serum TSH and free T4** promptly. [\[2\]](#cite-2 "Reference [2]")

Board pitfall: a normal first screen does **not** end the story in a high-risk infant. Preterm and VLBW infants, babies with Down syndrome, same-sex twins of an affected infant, and infants exposed to dopamine are at higher risk for delayed TSH rise or false-negative initial screening. If the baby has prolonged jaundice, hypoglycemia, macroglossia, large fontanelles, poor feeding, or pituitary red flags, check serum thyroid studies even if the newborn screen was reported as normal. [\[3\]](#cite-3 "Reference [3]")

SituationWhy it mattersPreterm/VLBW infant, Down syndrome, same-sex twin of an affected infantHigher risk of delayed TSH elevation; repeat screening around **10 to 14 days** is recommended. [\[3\]](#cite-3 "Reference [3]")Symptomatic infant with a “normal” screenCentral CH and late-evolving primary CH can be missed; send **serum TSH and free T4**. [\[4\]](#cite-4 "Reference [4]")

Levothyroxine is urgent, not elective
-------------------------------------

Treat suspected CH like a **medical emergency**. Discuss with pediatric endocrinology the same day, draw confirmatory serum tests, and start **levothyroxine (LT4)** immediately when the labs support the diagnosis—**definitely within 2 weeks of birth**. Do **not** wait for thyroid ultrasound or scintigraphy. Imaging helps with etiology, but it must never delay hormone replacement. Current guidance supports treatment when free T4 is low with elevated TSH, when **TSH is &gt;20 mU/L** even if free T4 is normal, and when **TSH remains &gt;6 mU/L beyond 21 days**. [\[4\]](#cite-4 "Reference [4]")

Start with **10 to 15 mcg/kg/day** once daily; use the higher end in severe disease. In a term infant, that usually means **37.5 or 50 mcg daily**. Give crushed tablets in a small amount of water. Avoid casual mixing with soy, iron, or calcium-heavy feeds that impair absorption. Boards love the trap of undertreating because the dose “feels high.” In CH, the initial dose is supposed to be aggressive because rapid biochemical correction is part of neuroprotection. [\[4\]](#cite-4 "Reference [4]")

> **Clinical Pearl:** If you are choosing between getting the thyroid scan today and getting the first LT4 dose today, choose the hormone. Imaging can wait; the brain cannot. [\[4\]](#cite-4 "Reference [4]")

Monitoring is where outcomes are won or lost
--------------------------------------------

Starting therapy is only half the job. During the first 3 years of life, aim to keep **free T4 or total T4 in the upper half of the age-specific reference range** while bringing TSH into the normal range. If T4 has not reached that upper half within 2 weeks, or TSH has not fallen below 20 mU/L within 4 weeks, think systematically: missed doses, wrong administration, malabsorption, or underdosing. Do not “watch and wait” through abnormal infancy labs. [\[5\]](#cite-5 "Reference [5]")

A practical high-yield schedule is this: recheck at **2 and 4 weeks** after treatment starts, then **every 1 to 2 months during the first year**, **every 2 to 3 months from 1 to 3 years**, and again about **2 weeks after any dose change**. At follow-up, do more than read numbers. Review how the family gives the medication, plot growth carefully, and keep hearing and developmental surveillance active. Overtreatment is not benign; it has been associated with **craniosynostosis** and abnormal brain and bone maturation. [\[5\]](#cite-5 "Reference [5]")

Developmental outcomes: reassuring, but only if you earn them
-------------------------------------------------------------

Modern outcomes are good. In the **vast majority** of infants detected early and treated adequately, growth, school performance, and overall neurodevelopment are normal, and severe intellectual disability has largely disappeared. Even infants with severe CH can reach normal IQ when treatment starts very early and at an adequate dose. [\[6\]](#cite-6 "Reference [6]")

The children who still do poorly are usually the ones who are **missed**, **treated late**, or **poorly controlled** in infancy. That is why developmental follow-up is not optional paperwork. If the cause is not clearly permanent, re-evaluate after **age 3 years** by stopping LT4 for **4 to 6 weeks** and repeating thyroid function tests. Do not label a child “lifelong hypothyroid” without proving it. [\[1\]](#cite-1 "Reference [1]")

Clinical Correlations
---------------------

On rounds, remember three rules. First, never let a normal newborn screen overrule a concerning exam in a preterm or syndromic infant. Second, never delay LT4 for imaging. Third, never accept “borderline” confirmatory labs without a plan: either treat, or repeat **serum TSH and free T4 within 1 to 2 weeks**. Those are exactly the errors that turn a screen-detected disease into a delayed diagnosis. [\[1\]](#cite-1 "Reference [1]")

Key Takeaways
-------------

- Most infants with CH are clinically subtle; the **newborn screen** is what saves neurodevelopment. [\[7\]](#cite-7 "Reference [7]")
- An abnormal screen requires **serum TSH and free T4**, not reassurance and not delay. [\[3\]](#cite-3 "Reference [3]")
- Start **levothyroxine 10 to 15 mcg/kg/day** promptly and **within 2 weeks of birth**. [\[4\]](#cite-4 "Reference [4]")
- Monitor aggressively in the first 3 years and target **T4 in the upper half of normal**. [\[5\]](#cite-5 "Reference [5]")
- If permanent disease is not established, reassess after **age 3 years** with a supervised trial off therapy. [\[1\]](#cite-1 "Reference [1]")

Conclusion
----------

Congenital hypothyroidism is one of Pediatrics’ clearest examples of why systems matter: screening finds it, but **timely LT4 and disciplined follow-up** are what protect the child. For boards and for practice, think fast, treat early, and monitor like the brain depends on it—because it does. [\[1\]](#cite-1 "Reference [1]")

    Frequently Asked Questions
----------------------------

    Should I wait for thyroid imaging before starting levothyroxine?

No. Draw confirmatory serum **TSH** and **free T4**, but do not delay treatment for ultrasound or scintigraphy if CH is biochemically supported.

   Which infants need repeat screening despite a normal first newborn screen?

Think about repeat screening in **preterm/VLBW infants**, infants with **Down syndrome**, and **same-sex twins** of an affected infant; delayed TSH rise is a classic pitfall.

   What is the usual starting dose of levothyroxine in congenital hypothyroidism?

Start **LT4 10 to 15 mcg/kg/day once daily**. Use the higher end for more severe disease.

   What lab pattern should I target during early treatment?

Aim for **free T4 or total T4 in the upper half of the age-specific reference range** and a normalizing **TSH**.

   When can I test whether hypothyroidism is transient rather than permanent?

If permanence is not already established, reassess after **3 years of age** with a supervised trial off levothyroxine, usually for **4 to 6 weeks**, followed by repeat thyroid function testing.

        References  (10)
-------------------

 1. 1.  [ Rose SR, et al. Congenital Hypothyroidism: Screening and Management. Pediatrics. 2022.     ](https://publications.aap.org/pediatrics/article/151/1/e2022060420/190308/Congenital-Hypothyroidism-Screening-and-Management)   [↩](#cite-ref-1-1 "Back to text")
2. 2.  [ newbornscreening.hrsa.gov/newborn-screening-process     ](https://newbornscreening.hrsa.gov/newborn-screening-process)   [↩](#cite-ref-2-1 "Back to text")
3. 3.  [ www.thyroid.org/patient-thyroid-information/ct-for-patients/march-2021/vol-14-issue-3-p-5-6     ](https://www.thyroid.org/patient-thyroid-information/ct-for-patients/march-2021/vol-14-issue-3-p-5-6/)   [↩](#cite-ref-3-1 "Back to text")
4. 4.  [ pedsendo.org/wp-content/uploads/2020/09/Infant-with-suspected-Congenital-hypothyroidism-final.pdf     ](https://pedsendo.org/wp-content/uploads/2020/09/Infant-with-suspected-Congenital-hypothyroidism-final.pdf)   [↩](#cite-ref-4-1 "Back to text")
5. 5.  [ fda.report/DailyMed/B8FB4DCD-2531-40D3-BBFB-CCDC8CE327C4.pdf     ](https://fda.report/DailyMed/B8FB4DCD-2531-40D3-BBFB-CCDC8CE327C4.pdf)   [↩](#cite-ref-5-1 "Back to text")
6. 6.  [ van Trotsenburg ASP, et al. Congenital Hypothyroidism: A 2020–2021 Consensus Guidelines Update. Thyroid. 2021.     ](https://pmc.ncbi.nlm.nih.gov/articles/PMC8001676/)   [↩](#cite-ref-6-1 "Back to text")
7. 7.  [ Health Resources and Services Administration. Congenital Hypothyroidism | Newborn Screening. Reviewed March 2026.     ](https://newbornscreening.hrsa.gov/conditions/congenital-hypothyroidism)   [↩](#cite-ref-7-1 "Back to text")
8. 8.  [ American College of Medical Genetics and Genomics. Newborn Screening ACT Sheet: Primary Congenital Hypothyroidism. Updated July 2024.     ](https://www.ncbi.nlm.nih.gov/books/NBK55827/bin/Primary-TSH-ACT-Sheet.pdf)
9. 9.  [ Pediatric Endocrine Society. Infant With Suspected Congenital Hypothyroidism.     ](https://pedsendo.org/clinical-resource/infant-with-suspected-congenital-hypothyroidism/)
10. 10.  [ DailyMed. Levothyroxine Sodium tablet label.     ](https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8e5e81ae-8cd5-574d-e053-2995a90aaf4c)

      Next

 Practice Pediatrics the way boards test
-----------------------------------------

 - Age‑specific differentials and management
- Growth, development, and immunizations
- Target weak areas with smart review

 [     Start practicing ](https://mdster.com/user/dashboard)  [     Pediatrics ](https://mdster.com/speciality/pediatrics)

   [ View pricing ](https://mdster.com/pricing) [ Explore features ](https://mdster.com/features)

  No credit card required. Full access to all features. No commitment. Cancel anytime.

  [     Back to all posts ](https://mdster.com/blog)

       Discussion  ()
-----------------

        Join the discussion

 [     Log in ](https://mdster.com/auth/login) or [     Sign up ](https://mdster.com/auth/register)

       No comments yet

Be the first to share your thoughts!

    ![]()

       Related Posts
-------------

  [   ![Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap](https://mdster.com/storage/blog/images/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap.jpg)        Medical Education

###  Anxiety, Depression, and Breathlessness in Severe COPD/Asthma Overlap

 A focused Family Medicine review of anxiety, depression, and dyspnea in severe COPD/asthma overlap, with safer prescribing, breathing retraining, and board-style pitfalls.

     6 min read

     0 comments

 ](https://mdster.com/blog/anxiety-depression-and-breathlessness-in-severe-copdasthma-overlap) [   ![IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy](https://mdster.com/storage/blog/images/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy.jpg)        Medical Education

###  IBS Subtypes and Diagnosis: Rome IV, IBS-C/D, and Colonoscopy

 A focused Internal Medicine review of IBS diagnosis: how to use Rome IV concepts, separate IBS-C from IBS-D and mixed IBS, and decide when colonoscopy is truly indicated.

     7 min read

     0 comments

 ](https://mdster.com/blog/ibs-subtypes-and-diagnosis-rome-iv-ibs-cd-and-colonoscopy) [   ![Chronic Pain Syndrome Overview: Anesthesiology Board Review](https://mdster.com/storage/blog/images/chronic-pain-syndrome-overview-anesthesiology-board-review.jpg)        Medical Education

###  Chronic Pain Syndrome Overview: Anesthesiology Board Review

 A board-focused overview of chronic pain syndrome for anesthesiology learners, emphasizing biopsychosocial thinking, safer prescribing, and function-first care.

     6 min read

     0 comments

 ](https://mdster.com/blog/chronic-pain-syndrome-overview-anesthesiology-board-review)

  [  ](/) Master your medical exams with evidence-based learning.

 [       GET IT ON Google Play

 ](https://play.google.com/store/apps/details?id=com.mdster.app)

### Platform

- [Home](https://mdster.com)
- [Features](https://mdster.com/features)
- [Pricing](https://mdster.com/pricing)
- [About](https://mdster.com/about)

### Resources

- [Blog](https://mdster.com/blog)
- [Dashboard](https://mdster.com/user/dashboard)

### Support

- [Contact](https://mdster.com/contact)
- [Legal &amp; Policies](https://mdster.com/legal)
- [Medical Reviewers](https://mdster.com/medical-reviewers)

 © 2026 MDster

 [    ](https://play.google.com/store/apps/details?id=com.mdster.app) [Terms](https://mdster.com/terms) [Privacy](https://mdster.com/privacy) [Editorial](https://mdster.com/editorial-policy)

     reCAPTCHA  Protected by reCAPTCHA.

 Google [Privacy Policy](https://policies.google.com/privacy) and [Terms of Service](https://policies.google.com/terms) apply.

Cookie Consent
--------------

 We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. [ Terms of Use ](https://mdster.com/terms) &amp; [ Privacy Policy ](https://mdster.com/privacy)

  Accept
